Corbus Pharmaceuticals Holdings, Inc.

CRBP

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001595097

SEC filings (opens in a new tab)

In the last 90 days, Corbus Pharmaceuticals Holdings, Inc. insiders filed 1 open-market purchase and 3 sales; 107 institutions reported holding it in 13F filings for Q2 2026, worth $129.1M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Corbus Pharmaceuticals Holdings, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026 All holders in Q1 2026

13F holders of CRBP: Q1 2026 compared with Q2 2026
Measure	Q1 2026	Of which not filed for Q2 2026	Q2 2026	Change
Holders	108	2	107	+1
Shares	12.9M	75.1K	13.8M	+938.1K (+7.3%)
Value	$121.2M	$704.9K	$129.1M	+$8.66M (+7.2%)

2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to CRBP in Q2 2026
Institution	Shares	Value	% of portfolio
Jones Hill Capital LP	653,572	$6.13M	1.30%
DAFNA Capital Management LLC	107,773	$1.01M	0.19%
Susquehanna Portfolio Strategies, LLC	75,979	$712.7K	0.01%
Charles Schwab Investment Management Inc	55,455	$520.2K	0.00%
HSBC Holdings PLC	55,224	$504.7K	0.00%
Bank of New York Mellon Corp	45,282	$424.7K	0.00%
Driehaus Capital Management LLC	38,977	$365.6K	0.00%
LMR Partners LLP	35,500	$333.0K	0.00%
Y-Intercept (Hong Kong) Ltd	22,646	$212.4K	0.00%
Nuveen, LLC	22,308	$209.2K	0.00%
Sectoral Asset Management Inc	20,000	$187.6K	0.13%
Susquehanna Fundamental Investments, LLC	18,852	$176.8K	0.00%
Panagora Asset Management Inc	16,087	$150.9K	0.00%
Deutsche Bank AG	16,071	$150.7K	0.00%
JPMorgan Chase & Co	6,854	$61.5K	0.00%
New York State Common Retirement Fund	6,600	$59.9K	0.00%
Police & Firemen's Retirement System of New Jersey	5,480	$51.4K	0.00%
Global Retirement Partners, LLC	1,800	$16.9K	0.00%
Legal & General Group Plc	1,596	$15.0K	0.00%
Ameritas Investment Partners, Inc.	1,494	$14.0K	0.00%
Atlantic Private Wealth, LLC	500	$4.69K	0.00%
Sterling Capital Management LLC	332	$3.11K	0.00%
Caitong International Asset Management Co., Ltd	41	$385	0.00%
Chilton Capital Management LLC	29	$273	0.00%

Sold out (23)

Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of CRBP in Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Armistice Capital, LLC	364,000	$3.42M
683 Capital Management, LLC	85,543	$803.2K
Assenagon Asset Management S.A.	85,246	$800.5K
Balyasny Asset Management LLC	65,201	$612.2K
Simplex Trading, LLC	52,836	$496.1K
Point72 Asset Management, L.P.	51,296	$481.7K
Prelude Capital Management, LLC	50,826	$477.3K
Hudson Bay Capital Management LP	29,578	$277.7K
D. E. Shaw & Co., Inc.	26,474	$248.6K
Exchange Traded Concepts, LLC	22,131	$207.8K
Laurion Capital Management LP	19,600	$184.0K
HRT Financial LP	18,660	$175.0K
Qube Research & Technologies Ltd	18,476	$173.5K
Omers Administration Corp	15,200	$142.7K
Bailard, Inc.	13,500	$126.8K
Group One Trading, L.P.	7,198	$67.6K
MAI Capital Management	126	$1.18K
Golden State Equity Partners	100	$939
Fortitude Family Office, LLC	64	$601
National Bank of Canada	46	$428
Clear Street Markets LLC	41	$385
Curio Wealth, LLC	23	$216
Scarborough Advisors, LLC	6	$56

Not filed for Q2 2026 yet (2)

Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CRBP in Q1 2026 that haven't filed for Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Deeter Investments LLP	75,000	$704.3K
CWM, LLC	69	$648